Search

Slight differences in clinical features can help physicians distinguish between two rare but similar forms of autoimmune brain inflammation in children, a new study by UT Southwestern scientists suggests.

More than 500 UT Southwestern Medical Center students, physicians, and health professionals will team up on Saturday, April 27 for the 15th annual Carnaval de Salud, which provides free health care services to underserved populations in Dallas.

Get Our News Need help? If you need assistance, please contact the Communications staff at 214-648-3404 . Receive our UT Southwestern News Releases in your email. First Name × Error: A field is missing data or special characters were used. Please correct. Last Name *Required × Error: A field is missing data or special characters were used. Please correct. Email Address (you@someplace.com) *Required × Error: A field is missing data or special characters were used. Please correct. Affiliation

A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center’s kidney cancer program.

Jere Mitchell, M.D., former director of the Harry S. Moss Heart Center at UT Southwestern Medical Center and an internationally recognized exercise physiologist whose seminal findings on maximal oxygen uptake changed conventional medical practice on bed rest and laid the foundation for central

Mutations in a gene related to HER2, a gene frequently implicated in breast cancers and a variety of other malignancies, can amplify activity that spurs tumor growth

UT Southwestern stem cell scientists find that stringent lineage tracing is crucial for studies of nerve cell regeneration.

Using a virus to purposely mutate genes that produce cancer-driving proteins could shed light on the resistance that inevitably develops to cancer drugs that target them, a new study led by UT Southwestern scientists suggests.

Depression screening among cancer patients improved by 40 percent to cover more than 90 percent of patients under a quality improvement program launched by a multidisciplinary team at UT Southwestern Medical Center and Southwestern Health Resources.

A new treatment that combines two existing medications may provide long-sought relief for many battling debilitating methamphetamine use disorder, according to a study to be published tomorrow in The New England Journal of Medicine.